Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
Cancer Research, 11/03/09
Ciro M et al. – ATAD2 expression is high in several human tumors and that the expression levels correlate with clinical outcome of breast cancer patients. ATAD2 links the E2F and MYC pathways and contributes to the development of aggressive cancer through the enhancement of MYC–dependent transcription.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2
Virchows Archiv, 11/25/09
DcR1 expression in endometrial carcinomas
Virchows Archiv, 11/25/09
Role of caspase 8 as a determinant in trail sensitivity of neuroblastoma cell lines
Pediatric Hematology and Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


